Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

349results about How to "High acceptability" patented technology

Mechanism for authentication and authorization for network and service access

There is proposed a network access authentication and authorization mechanism in which an authentication session in an authentication, authorization and accounting procedure for a user equipment for providing an initial network access is executed. A first identification element related to the user equipment is obtained. Then, a user credential validation procedure is performed wherein a second identification element related to the user equipment or related to a user of the user equipment is obtained. The obtained first and second identification elements are processed for determining whether a match between the first and second identification elements exists. In addition, the authentication session executed for the user equipment is identified on the basis of the result of the processing of the first and second identification elements. Then, a change of an authorization of the user equipment is executed for providing a modified network access.
Owner:NOKIA SOLUTIONS & NETWORKS OY

Lane change assist system

InactiveUS20140074356A1Minimum effort and stressMinimum effortSteering initiationsDigital data processing detailsDriver/operatorEngineering
A lane change assist system allows a vehicle driver to change lanes with minimum effort and stress by offering appropriate lane change options depending on the conditions of an ego vehicle and surrounding vehicles. The system includes a driving assessment device (6) configured to determine one of a plurality of driving alternatives according to signals from an ego vehicle sensing device (4), an object vehicle sensing device (2) and a driver intention detecting device (5), the driving alternatives including at least staying on a current lane, changing lanes before the object vehicle and changing lanes behind the object vehicle. The system further comprises a lane change program selection device (7) configured to select one of a plurality of pre-set lane change programs according to the determined driving alternative and other data.
Owner:HONDA MOTOR CO LTD

Aerosol Dispensing Device

An aerosol dispensing device comprises a tubular body (2, 3) that provides a plenum (32), a mouthpiece (1) having an outlet (34), a valve (17) for dispensing fluid from a canister (5) as an aerosol with relatively large and small droplet sizes into the plenum for supply to a user through the mouthpiece, and a baffle arrangement (26, 27) that provides first (33) and second (36) passageways each coupled at one end to the plenum and so configured to receive relatively small and large size droplets in the aerosol respectively, the other end of the first passageway (33) extending to the outlet (34) in the mouthpiece to supply the small size droplets to the user, and the other end of the second passageway (36) being closed to inhibit passage of the large size droplets to the mouthpiece outlet, and containing a absorbent pad (31) to prevent leakage of liquid from the canister. The pad (31) may be pre-loaded with a flavourant.
Owner:NICOVENTURES HLDG

Automotive self-adaptive cruising system with multi-mode switching system and control method thereof

The invention discloses an automotive self-adaptive cruising system with a multi-mode switching system and a control method thereof. The system is divided into three layers of control structures including a mode switching layer, an upper-layer controller and a low-layer controller; a set of automobile traveling mode comprehensively arbitrating and switching mechanism is designed in the mode switching layer and is used for picking out the ideal working mode which is most suitable for the current traveling working condition from ten control modes. The ten control modes include the constant-speed cruising mode, the steady-state automobile following mode, the front automobile approaching mode, the urgent acceleration mode, the forcible deceleration mode, the curve mode, the lane changing assisting mode, the collision avoidance mode, the doubling mode and the switching-out mode. The upper-layer controller is responsible for specifically achieving the corresponding control mode and conducting continuous handling before an expected accelerated speed is output so as to avoid sudden change of the accelerated speed; the lower-layer controller is responsible for tracking the expected accelerated speed by controlling an execution mechanism of the automobile. According to the automotive self-adaptive cruising system with the multi-mode switching system and the control method thereof, the multi-mode switching system is adopted, in this way, the automotive self-adaptive cruising system can be better adapted to a complicated traveling environment, and the acceptability of drivers is improved.
Owner:WUHAN UNIV OF TECH

Financial services payment vehicle and method

A financial services payment vehicle is disclosed having a database stored on a computer readable media, the database including records associated with a plurality of active financial services card accounts, one of the financial services card account records having a name representing a cardholder for purposes of using the account, the name having a first part selected by the cardholder and a second part selected by a second party unrelated to the cardholder.A financial services method is also disclosed involving selecting a first part of a cardholder name for an account which would appear on a financial services card if a physical card is issued, accepting an unrelated entity's selection of a second part of the cardholder name for the account such that a use of the account will result in a provision of the first part in place of a first name and the second part in place of a surname.An additional financial services method is disclosed involving a using step for making a purchase with a financial services card, the financial services card including a cardholder name having a first part selected in a first selecting step by an individual in whose name the financial services card is registered, and a second part selected in a second selecting step, the second part identifying an entity other than the individual.
Owner:CITIBANK

Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage

Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed.
Owner:MAC FARMS

Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage

Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed.
Owner:MAC FARMS

Self-Adaptive Cement Systems

A self-healing cement system includes cement, water and at least one additive that swells in contact with water from reservoir or from formation in the case of a structural failure in the set cement to provide a physical barrier in the zone of failure. Examples of such material include particles of super-absorbent polymer. These additives have the effect of making the cement self-healing in the event of physical failure or damage such as micro-annuli. The self healing property is produced by the contact of the water itself, the potential repair mechanism is thus activated if and when needed in case of start of loss of zonal isolation. Several super-absorbent polymers have been identified such as polyacrylamide, modified crosslinked poly(meth)acrylate and non-solute acrylic polymers.
Owner:SCHLUMBERGER TECH CORP

Identification band using a conductive fastening for enhanced security and functionality

An identification device formed from a band of material and a non-reusable tamper-resistant fastening arranged to join opposite end regions of the band. A Radio Frequency Identification (RFID) transponder is disposed in the band. The transponder includes and RFID circuit, such as may be formed on an integrated circuit (IC) chip, and an antenna. In the present invention, the tamper-resistant fastening serves additional functions beyond securing the opposite end regions of the band together. Namely, the fastening can be made of a conductive material and designed to create electrical continuity between multiple conductors to enable or disable certain circuit functionality. In one variation, this continuity allows the excess tail portion of the wristband to be cut without disrupting circuit functionality. In another variation, the fastening mechanism is designed to crimp conductors together. In yet another embodiment, the RFID circuit itself is wholly or partially formed within the fastening mechanism to increase the better protect and support the circuit, as well as to make it more difficult to defeat the tamper-resistant functionality of the device.
Owner:BARTRONICS HONG KONG

Aqueous polyimide precursor solution composition and method for producing aqueous polyimide precursor solution composition

InactiveUS20130171520A1High environmental acceptabilityEasy to produceElectrolytic capacitorsHybrid capacitor electrodesSolubilitySolvent
A method for producing an aqueous polyimide precursor solution composition, including reacting a tetracarboxylic dianhydride and a diamine, which has a solubility in water at 25° C. of 0.1 g / L or more, in the presence of an imidazole, using water as a reaction solvent to provide an aqueous polyimide precursor solution composition.
Owner:UBE IND LTD

Nanoparticle formulations with enhanced mucosal penetration

Hypotonic formulations were evaluated for delivering water-soluble drugs and for drug delivery with muco-inert (that is, non-adhesive) mucus-penetrating nanoparticles (MPP). Hypotonic formulations markedly increased the rate at which drugs and MPP reached the epithelial surface, including deep into the vaginal folds. Minimally hypotonic formulations, preferably ranging from 20-220 mOsm / kg, provided rapid and uniform delivery of MPP to the entire vaginal surface, with minimal risk of epithelial toxicity. Data also show that there is a higher osmolality in the colon, such that vehicles with an osmolality above that of blood plasma (generally considered isotonic at ˜300 mOsm / kg), still lead to improvements in distribution in the colon due to rapid, osmotically-induced fluid absorption. The range for improved colon distribution with a hypotonic vehicle in the colon is ˜20 mOsm / kg-450 mOsm / kg.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE

Sprayable compositions comprising a combination of pharmaceutical active agents, an alcohol phase, at least one volatile silicone and a non-volatile oily phase

Sprayable, anhydrous and physically / chemically stable dermatological / pharmaceutical compositions, well suited for the treatment of a variety of dermatological disorders, notably psoriasis, contain: a) a therapeutically effective amount of a solubilized corticord; notably clobetasol propionate; b) a therapeutically effective amount of a solubilized vitamin D derivative, notably calcitriol; c) an alcohol phase; d) at least one volatile silicone; and e) a non-volatile oily phase which comprises one or more oils; formulated into f), a sprayable and topically applicable, dermatologically / pharmaceutically acceptable vehicle therefor.
Owner:GALDERMA SA

Liquid nutritional compositions containing unsaturated fatty acids

Disclosed are liquid nutritional compositions comprising: carbohydrate; lipid having from about 0.1% to about 20% of an n-3 polyunsaturated fatty acid, n-6 polyunsaturated fatty acid, or combinations thereof by weight of the composition; a protein matrix having from about 15% to about 50% of a whey protein fraction by weight of the total protein in the composition; and a limonene-containing material, cranberry oil, or combinations thereof. The compositions are preferably aseptically packaged, and provide enhanced oxidative stability, flavor, and aroma, especially when formulated with relative high polyunsaturated fatty acid concentrations.
Owner:ABBOTT LAB INC

Retractable needle single use safety syringe

InactiveUS7481797B2Simple and reliable mechanismLow costGuide needlesInfusion syringesEngineeringSafety syringe
A safety syringe assembly includes an elongated, generally cylindrical barrel having a hollow interior forming a hollow nozzle located at a distal end of the barrel and opening into the interior of the barrel. A plunger is slidably mounted in the barrel and has a longitudinal open channel. A needle holder mounts a needle at a distal end thereof and is slidably mounted in the longitudinal open channel of the plunger for movement between an advanced position in which the needle on the distal end of the needle holder projects from a distal end of the nozzle, and a retracted position in which the needle is retracted within the barrel. A compression spring is mounted inside of the barrel, and a spring retainer element has a spring support portion extending from the interiorly of the barrel to a portion for mounted within the barrel and supporting a distal end portion of the spring against expansion. The spring urges the needle holder toward its retracted position. A latch has a closed position in which the needle holder is latched relative to the barrel to hold the needle holder in its advanced position against the urging of the spring, and an open position in which the needle holder is unlatched relative to the barrel to allow the spring to expand in a proximal direction to move the needle holder to its retracted position.
Owner:UNIVERSAL SAFETMED DEVICES LLC

Sprayable compositions comprising a combination of pharmaceutical active ingredients, an alcohol phase and an oily phase

Sprayable, anhydrous and physically / chemically stable dermatological / pharmaceutical compositions, well suited for the treatment of a variety of dermatological disorders, notably psoriasis, contain: a) a therapeutically effective amount of a solubilized corticoid, notably dissolved clobetasol propionate; b) a therapeutically effective amount of a solubilized vitamin D derivative, notably dissolved calcitriol; and c) an alcohol phase; and d) an oily phase which comprises one or more oils; formulated into e), a sprayable and topically applicable, dermatologically / pharmaceutically acceptable vehicle therefor.
Owner:GALDERMA SA

Therapeutic field generator device and method

A portable therapeutic field generator device (10) generates a reduced magnetic field component for a relatively large electric field by virtue that adjacent conductive tracks in a radiating element (40, 50) conduct electrical current in opposing directions. The device (10) includes a processor (12) that, in response to a control algorithm stored in memory (14), supplies a pulse wave (22) to a circuit containing the radiating element (40, 50). The pulse establishes generation of a base heartbeat reference having a frequency around a nominal heart rate. At periodic times, the base heart beat reference is supplemented by mutually exclusive periods of alpha wave, theta wave and delta wave generation (or other selected frequencies below about 200 Hz) based on selected brainwave frequencies for these waves, with the pulses having a duration generally corresponding to that ascribed to neuron depolarisation pulses. The device (10) cycles through multiple cycles (88) and, dependent upon the effect that is desired, may see delta wave frequencies follow theta wave frequencies that follow alpha wave frequencies. Delays may exist between transitions between the generated waves, with delta wave generation occurring no later than sixty minutes from commencement of alpha wave production for a mode that induces sleep. Delta waves production has, typically, a duration that is twice that of either the alpha or theta wave production. A second mode of operation sees longer pulse times for higher frequencies—between about 100 Hz and 500 Hz—associated with muscle stimulation.
Owner:ZEEZ TECH

Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof

InactiveUS20090258947A1Low costProphylaxis, amelioration and/orBiocideNervous disorderDiseaseSide effect
Low dose pharmaceutical dosage form comprising nimesulide or its pharmaceutically acceptable salts, esters, solvates or hydrates thereof, along with one or more pharmaceutically acceptable excipient(s) are provided. The present invention also provides process of preparing such dosage forms and therapeutic methods of using such dosage forms. The low dose compositions 10 are designed to exhibit such bioavailability, which is effective in the treatment of NSAID indicated disorders particularly, which require long-term treatment regimens such as arthritis. Such compositions reduce the cost of therapy in diseases, which require long-term therapies, are easy to manufacture, and also result in the reduction of dose related side effects associated with nimesulide therapy.
Owner:PANACEA BIOTEC

Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives

Novel 2′-C-methyl nucleoside 5′-monophosphate and 4′-C-methyl nucleoside 5′-monophosphate derivatives, stereoisomers, and pharmaceutically acceptable salts or prodrugs thereof, their preparation, and their uses for the treatment of hepatitis C viral infection are described.
Owner:METABASIS THERAPEUTICS INC +1

Transdermal norelgestromin delivery system

A system for transdermal delivery of norelgestromin (NGMN) to an individual. The system has a high NGMN loading with suitable permeation enhancers to effect therapeutic flux rate. Polyacrylate drug reservoir with the NGMN and high loading of one or more of permeation enhancers and NGMN dissolved therein provides desirable adhesive characteristics and effective transdermal therapeutic properties. Estrogen can be delivered with the NGMN.
Owner:ALZA CORP

Disposible safety syringe with improved retractable needle

A safety syringe assembly includes an elongated, generally cylindrical barrel having a hollow interior forming a hollow nozzle located at a distal end of the barrel and opening into the interior of the barrel. A plunger is slidably mounted in the barrel and has a longitudinal open channel. A needle holder mounts a needle at a distal end thereof and is slidably mounted in the longitudinal open channel of the plunger for movement between an advanced position in which the needle on the distal end of the needle holder projects from a distal end of the nozzle, and a retracted position in which the needle is retracted within the barrel. A compression spring is mounted inside of the barrel, and a spring retainer element has a spring support portion extending from the interiorly of the barrel to a portion for mounted within the barrel and supporting a distal end portion of the spring against expansion. The spring urges the needle holder toward its retracted position. A latch has a closed position in which the needle holder is latched relative to the barrel to hold the needle holder in its advanced position against the urging of the spring, and an open position in which the needle holder is unlatched relative to the barrel to allow the spring to expand in a proximal direction to move the needle holder to its retracted position.
Owner:萨克哈拉姆·D·马赫卡

Lead-acid battery

InactiveUS20030049528A1Improved high-efficiency charging characteristicImprove charging characteristicsLead-acid accumulatorsFinal product manufactureHybrid carElectric cars
The present invention provides a lead-acid battery superior in high-efficiency charging characteristic to conventional lead-acid batteries; and a carbon material used in the lead-acid battery, having excellent charge acceptability. That is, the present invention provides a lead-acid battery which uses, as an additive to the anode active material, a simple substance and / or a compound thereof, both having a catalysis for desulfurization or a catalysis for SOX oxidation by adding to or loading on a carbon material such as active carbon, carbon black or the like and thereby has superior high-efficiency charging characteristic and improved charging acceptability. When such a lead-acid battery whose anode contains a carbon material containing or loading thereon the above simple substance and / or compound, is applied to electric cars, various hybrid cars, power storage systems, elevators, electromotive tools and power source systems such as uninterruptible power source, distributed power source and the like, all having high input and output requirements, stable control can be obtained.
Owner:SHIN KOBE ELECTRIC MASCH CO LTD

Retractable needle single use safety syringe

InactiveUS20070060893A1Simple and reliable mechanismLow costGuide needlesInfusion syringesSafety syringeNeedle holder
A safety syringe assembly includes an elongated, generally cylindrical barrel having a hollow interior forming a hollow nozzle located at a distal end of the barrel and opening into the interior of the barrel. A plunger is slidably mounted in the barrel and has a longitudinal open channel. A needle holder mounts a needle at a distal end thereof and is slidably mounted in the longitudinal open channel of the plunger for movement between an advanced position in which the needle on the distal end of the needle holder projects from a distal end of the nozzle, and a retracted position in which the needle is retracted within the barrel. A compression spring is mounted inside of the barrel, and a spring retainer element has a spring support portion extending from the interiorly of the barrel to a portion for mounted within the barrel and supporting a distal end portion of the spring against expansion. The spring urges the needle holder toward its retracted position. A latch has a closed position in which the needle holder is latched relative to the barrel to hold the needle holder in its advanced position against the urging of the spring, and an open position in which the needle holder is unlatched relative to the barrel to allow the spring to expand in a proximal direction to move the needle holder to its retracted position.
Owner:UNIVERSAL SAFETMED DEVICES LLC

Nanoparticle formulations with enhanced mucosal penetration

Hypotonic formulations were evaluated for delivering water-soluble drugs and for drug delivery with muco-inert (that is, non-adhesive) mucus-penetrating nanoparticles (MPP). Hypotonic formulations markedly increased the rate at which drugs and MPP reached the epithelial surface, including deep into the vaginal folds. Minimally hypotonic formulations, preferably ranging from 20-220 mOsm / kg, provided rapid and uniform delivery of MPP to the entire vaginal surface, with minimal risk of epithelial toxicity. Data also show that there is a higher osmolality in the colon, such that vehicles with an osmolality above that of blood plasma (generally considered isotonic at ˜300 mOsm / kg), still lead to improvements in distribution in the colon due to rapid, osmotically-induced fluid absorption. The range for improved colon distribution with a hypotonic vehicle in the colon is ˜20 mOsm / kg-450 mOsm / kg.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE

Electrode and battery

A battery includes a positive electrode, a negative electrode, and an electrolyte. At least one of the positive electrode and the negative electrode is an electrode containing an active material and an inorganic oxide. The inorganic oxide is in a state of being extractable with tetrahydrofuran or methyl ethyl ketone at normal temperature.
Owner:MURATA MFG CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products